Ozempic and Dysuria aggravated - a phase IV clinical study of FDA data

Summary:

Dysuria aggravated is reported as a side effect among people who take Ozempic (semaglutide), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Metformin, and have Type 2 diabetes.

The phase IV clinical study analyzes which people have Dysuria aggravated when taking Ozempic. It is created by eHealthMe based on reports of 28,954 people who have side effects when taking Ozempic from the FDA, and is updated regularly.

What is Ozempic?

Ozempic has active ingredients of semaglutide. It is often used in weight loss. eHealthMe is studying from 29,761 Ozempic users. Check the latest studies of Ozempic.

What is Dysuria aggravated?

Dysuria aggravated (painful or difficult urination) is found to be associated with 1,179 drugs and 409 conditions by eHealthMe. Check the latest studies of Dysuria aggravated.

On Jul, 26, 2026

28,954 people reported to have side effects when taking Ozempic.
Among them, 66 people (0.23%) have Dysuria aggravated.

Among these 66 people:

How long have people been on Ozempic when they have Dysuria aggravated? *

What is the gender of people who have Dysuria aggravated when taking Ozempic? *

female: 47.62 %
male: 52.38 %

What is the age of people who have Dysuria aggravated when taking Ozempic? *

What are other drugs people take besides Ozempic? *

What are other side effects people have besides Dysuria aggravated? *

Nausea (feeling of having an urge to vomit): 22 people, 33.33%
Diarrhea: 14 people, 21.21%
Abdominal Pain Upper: 12 people, 18.18%
Nausea And Vomiting: 12 people, 18.18%
Headache (pain in head): 11 people, 16.67%
Fatigue (feeling of tiredness): 11 people, 16.67%
Constipation: 9 people, 13.64%
Dizziness: 9 people, 13.64%
Urinary Tract Infection: 9 people, 13.64%
Weakness: 8 people, 12.12%

What are the existing conditions these people have? *

Type 2 Diabetes: 26 people, 39.39%
Diabetes: 10 people, 15.15%
Indigestion: 3 people, 4.55%
Immunodeficiency Common Variable: 3 people, 4.55%
Hiv Infection: 2 people, 3.03%
Hypergammaglobulinaemia (elevated levels of gamma globulin): 2 people, 3.03%
High Blood Pressure: 2 people, 3.03%
Fabry's Disease (build up of a particular type of fat, called globotriaosylceramide, in the body's cells): 1 person, 1.52%
Chest Pain: 1 person, 1.52%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 1 person, 1.52%

* Approximation only. Some reports may have incomplete information.

Do you take Ozempic and have Dysuria aggravated?

- Check whether Dysuria aggravated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Ozempic:

Ozempic (29,761 reports)

Browse all side effects of Ozempic:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Dysuria aggravated:

Dysuria aggravated (1,179 drugs)

Browse all the conditions that are associated with Dysuria aggravated:

Dysuria aggravated (409 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on semaglutide (the active ingredients of Ozempic) and Ozempic (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.